SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-03-001070
Filing Date
2003-10-31
Accepted
2003-10-31 16:51:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13da.htm SC 13D/A 84929
3 EXHIBIT 1 ex1.htm EX-1 11567
  Complete submission text file 0000898432-03-001070.txt   98698
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45946 | Film No.: 03970391
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice